Literature DB >> 1569675

The urological manifestations of chronic granulomatous disease.

M M Walther1, H Malech, A Berman, P Choyke, D J Venzon, W M Linehan, J I Gallin.   

Abstract

Chronic granulomatous disease is a rare disorder of phagocytic cell oxidative metabolism. Patients have recurrent infections with catalase positive organisms and granulomatous lesions throughout the body. The genitourinary tract can be an occult site of involvement. We reviewed the prevalence of urological abnormalities in 60 patients with chronic granulomatous disease. Chart review revealed that 23 of the 60 patients (38%) had urological manifestations. Seven patients had 10 ureteral strictures. Treatment of the granulomatous strictures with steroids caused at least a temporary decrease in size or a resolution of the granulomas and strictures with steroids caused at least a temporary decrease in size or a resolution of the granulomas and relief of the obstruction. Three patients had bladder granulomas and 1 had a urethral stricture. A total of 12 patients had urinary tract infections and 7 had altered renal function. Ten patients had other manifestations of genitourinary disease. Abnormalities in the urinary tract are relatively frequent. Risk factors include X-linked disease and low percentile weight. Genitourinary manifestations can cause significant morbidity in chronic granulomatous disease patients. A variety of therapies, including judicious use of steroids and gamma-interferon, are proving to be useful in the treatment of this disorder and in some cases they may offer a nonoperative alternative for relief of chronic granulomatous obstructive disease in these patients.

Entities:  

Mesh:

Year:  1992        PMID: 1569675     DOI: 10.1016/s0022-5347(17)37552-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  18 in total

Review 1.  Chronic granulomatous disease.

Authors:  Steven M Holland
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

2.  Renal Disease in Chronic Granulomatous Disease: Data from the USIDNET Registry.

Authors:  Keith A Sacco; Elizabeth Garabedian; Kathleen E Sullivan; Avni Y Joshi
Journal:  J Clin Immunol       Date:  2018-07-05       Impact factor: 8.317

3.  Follow up of patients with chronic granulomatous disease diagnosed since 1990.

Authors:  C M Cale; A M Jones; D Goldblatt
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 4.  Prostatic abscess in a pediatric patient with chronic granulomatous disease: report of a unique case and review of the literature.

Authors:  Nnenaya Q Agochukwu; Ardeshir R Rastinehad; Lee A Richter; Stephanie Barak; Christa S Zerbe; Steven M Holland; Peter A Pinto
Journal:  J Pediatr Surg       Date:  2012-02       Impact factor: 2.545

5.  Diabetes, renal and cardiovascular disease in p47 phox-/- chronic granulomatous disease.

Authors:  Jennifer W Leiding; Beatriz E Marciano; Christa S Zerbe; Suk See Deravin; Harry L Malech; Steven M Holland
Journal:  J Clin Immunol       Date:  2013-02-06       Impact factor: 8.317

Review 6.  Chronic granulomatous disease.

Authors:  Steven M Holland
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-22       Impact factor: 3.722

Review 7.  Inflammatory manifestations in chronic granulomatous disease (CGD).

Authors:  S D Rosenzweig
Journal:  J Clin Immunol       Date:  2008-01-12       Impact factor: 8.317

8.  Rapidly progressive IgA vasculitis-associated nephritis successfully treated with immunosuppressive therapy in an adolescent with chronic granulomatous disease.

Authors:  Mari Tanaka; Keisuke Taniguchi; Sho Miki; Sachio Iwanari; Masaki Ikeda; Masafumi Hasui; Hiroya Takeoka
Journal:  CEN Case Rep       Date:  2021-03-08

Review 9.  Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase.

Authors:  Michela G Schäppi; Vincent Jaquet; Dominique C Belli; Karl-Heinz Krause
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

10.  Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease.

Authors:  Alessandra Magnani; Nizar Mahlaoui
Journal:  Paediatr Drugs       Date:  2016-10       Impact factor: 3.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.